Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BotuCiSter: Botox for Sternotomy Scars
NCT07013240Phase 3Not yet recruiting
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Jul 2025
- Primary completion
- Feb 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in Hypertrophic Scar (HS), keloid, sponsored by Centre Hospitalier Universitaire de Bordeaux. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
Hypertrophic Scar (HS)keloid
Beyond the preview
Go deeper on NCT07013240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07013240.